A carregar...
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator
Channel activators (potentiators) of cystic fibrosis (CF) transmembrane conductance regulator (CFTR), can be used for the treatment of the small subset of CF patients that carry plasma membrane-resident CFTR mutants. However, approximately 90% of CF patients carry the misfolded ΔF508-CFTR and are po...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Landes Bioscience
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3494594/ https://ncbi.nlm.nih.gov/pubmed/22874563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/auto.21483 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|